Skip to main content
ScienceDirect
  • Journals & Books
  • Search
My account
Sign in
Go to journal home page - Journal of the National Cancer Center

Journal of the National Cancer Center

    • Latest issue
    • All issues
    • Articles in press
    • Special issues and article collections
Submit your articleGuide for authors

About the journal

Aims & Scope

The Journal of the National Cancer Center (JNCC) is a peer-reviewed and fully open-access journal that publishes high-quality articles in all areas of cancer research. Launched in March 2021, the journal aims to promote studies that answer fundamental questions of cancer biology and epidemiology, and facilitate state-of-the-art approaches for cancer prevention, detection, diagnosis, and treatment. As a prominent platform to communicate advances in cancer research and cancer-related health policies, the journal presents original research articles, news stories, systematic and focused reviews, commentaries, brief communications, correspondences, and editorials.

JNCC adopts an efficient process of rigorous yet rapid review of submitted manuscripts so that timely findings of significant scientific impact can be published with minimal delay. JNCC particularly encourages submission of randomized controlled clinical trials, for which expedited review process will be provided. The journal now publishes on a bimonthly basis.

JNCC is supervised by the National Health Commission of China and is sponsored by the National Cancer Center (NCC). NCC is the national authority for cancer prevention and control in China.

The main responsibilities of NCC include:

  • Assist the National Health Commission in developing national cancer prevention and control strategies;

  • Organize and oversee the national cancer registration network, release the annual report of the national cancer registry;

  • Establish clinical guidelines for cancer diagnosis and treatment;

  • Promote and facilitate clinical trials for new drugs and devices for cancer treatment;

  • Build programs for cancer screening and early detection;

  • Develop and implement effective cancer primary preventive strategies;

  • Conduct scientific research on cancer prevention and control;

  • Carry out relevant trainings, academic exchanges, and international cooperation with International Agency for Research on Cancer (IARC), U.S. National Cancer Institute (NCI), Asian National Cancer Center Alliance (ANCCA), Cancer Research UK (CRUK), and prestigious universities, etc.;

  • Undertake other tasks assigned by the National Health Commission.

The editorial office of JNCC is in Beijing, China.

P-ISSN 2096-8663

The Journal of the National Cancer Center (JNCC) is a peer-reviewed and fully open-access journal that publishes high-quality articles in all areas of cancer research. Launched in March 2021, the journal aims to promote studies that answer fundamental questions of cancer biology and epidemiology, …

Article publishing option

Open Access

Discounted Article Publishing Charge (APC): Free. This discount is valid for articles submitted by 31 December 2025.
Full APC without discount: USD 2,700 (excluding taxes).
Review this journal’s open access policy.
1 day
Submission to first decision
54 days
Submission to decision after review
146 days
Submission to acceptance
5 days
Acceptance to online publication
View all insights

Editor-in-Chief

View full editorial board
Photo of Jie He, MD

Jie He, MD

Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Articles

Short communicationOpen access

Neoantigen identification and TCR-T therapy development for solid tumors: current advances and future perspectives

Xinyao Zheng, ... Zhihua Liu
October 2025View PDF
Review articleOpen access

Neuromuscular complications associated with cancer immunotherapy

Ge Xiong, ... Tianhong Li
October 2025View PDF
Review articleOpen access

Revealing the landscape of targeting mitochondrial functions and behaviors to overcome cancer chemoresistance

Haoyan Zhang, ... Jun Pang
October 2025View PDF
Review articleOpen access

Prostate cancer in China: epidemiological trends, genomic insights, and future directions for optimized management

Zhongyuan Wang, ... Dingwei Ye
October 2025View PDF
Research articleOpen access

Long-term exposure to ozone and incidence of lung cancer in China: data based on a national population cohort (ChinaHEART)

Yi Wu, ... Xi Li
October 2025View PDF
Research articleOpen access

Score-based prediction model for female hepatocellular carcinoma surveillance in asymptotic HBsAg carriers: a multicenter cohort study in China

Mengdi Cao, ... Wanqing Chen
October 2025View PDF
Research articleOpen access

Spatial and maturity heterogeneity of tertiary lymphoid structures shapes immune microenvironment and progression in prostate cancer

Zhongyuan Wang, ... Wenhao Xu
October 2025View PDF
Research articleOpen access

Transcriptomic predictors of prostate cancer recurrence following focal cryotherapy: a pooled analysis of phase II trial and prospective cohort data

Kae Jack Tay, ... Melvin Lee Kiang Chua
October 2025View PDF
Read latest issue

Calls for papers

Tumor microenvironment and immunotherapy: from bench to bedside (Volume II)

Guest editors: Professor Dingwei Ye, Professor Hailiang Zhang
Immunotherapies, particularly immune checkpoint inhibitors (ICIs), have revolutionized the cancer treatment paradigms. However, the variability in clinical responses has sparked considerable interest in further understanding these therapies.
Submission deadline: 30 November 2025

Statistical Perspectives and Best Practice in Oncology Clinical Trials

Guest editors: Chen HU, Xiaofei WANG, Haitao PAN
Clinical trials are the cornerstone of advancing oncology research and improving patient care. Meanwhile they also face numerous challenges to keep up with the rapid developments in drug development, cancer biology and precision medicine. Clinical …
Submission deadline: 31 December 2025
View all calls for papers for special issues
More opportunities to publish your research:
Browse open Calls for Papers

Special issues and article collections

Tumor microenvironment and immunotherapy: from bench to bedside (Volume II)

Edited by Professor Hailiang Zhang, Professor Dingwei Ye
8 September 2025

Work at night, sleep loss, fatigue and cancer: exposure, mechanisms, and epidemiological evidence

Edited by Pierluigi Cocco
1 July 2025

Decoding Prostate Cancer Therapy Resistance and Novel Therapeutic Strategies

Edited by Dr. Haojie Huang
5 May 2025

Tumor microenvironment and immunotherapy: from bench to bedside

Edited by Hailiang Zhang, Dingwei Ye
29 April 2025
View all special issues and article collections
View all issues
Online ISSN: 2667-0054

Copyright © 2025 Chinese National Cancer Center. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

For authors
Resources for authorsTrack your accepted paperJournal FinderResearcher AcademyRights and permissionsJournal Article Publishing Support Center
For editors
Resources for editorsPublishing Ethics Resource KitGuest editors
For reviewers
Resources for reviewersReviewer recognition
  • About ScienceDirect
  • Remote access
  • Contact and support
  • Terms and conditions
  • Privacy policy

Cookies are used by this site.

All content on this site: Copyright © 2025 Elsevier B.V., its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.

We use cookies that are necessary to make our site work. We may also use additional cookies to analyze, improve, and personalize our content and your digital experience. You can manage your cookie preferences using theCookie settings link. For more information, see ourCookie Policy
Company Logo

Cookie Preference Center

We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our Cookie Policy and the list of Google Ad-Tech Vendors.

You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer. See the different category headings below to find out more or change your settings.

Manage Consent Preferences

Strictly Necessary Cookies

Always active

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work.

Functional Cookies

These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site.

Contextual Advertising Cookies

These cookies are used for properly showing banner advertisements on our site and associated functions such as limiting the number of times ads are shown to each user.

Cookie List

Search Icon
label
Consent Leg.Interest
label
label
label
    Powered by Onetrust
    Image of ScienceDirect AI search screen

    Research faster with ScienceDirect AI

    Ask complex questions your way and instantly find what you need from millions of peer-reviewed, full-text articles and book chapters.